Insider Stock Trading History of Simpson Todd E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Simpson Todd E since year 2005. The trader's CIK number is 1216477. At the time of this reporting, Simpson Todd E is the Chief Financial Officer of Seattle Genetics Inc /wa . (stock ticker symbol SGEN). See this page for all insider trading activities at Seattle Genetics Inc /wa .


Stock purchases, sales, and option exercises reported by insider Simpson Todd E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-01 SGEN Seattle Genetics Inc /wa Sale 39,385 61.24 2,412,134
2017-09-06 SGEN Seattle Genetics Inc /wa Sale 9,638 52.00 501,176
2017-08-28 SGEN Seattle Genetics Inc /wa Sale 4,937 47.90 236,457
2016-08-22 SGEN Seattle Genetics Inc /wa Sale 3,991 46.59 185,944
2015-09-29 SGEN Seattle Genetics Inc /wa Option Ex 14,801 13.73 203,217
2015-08-20 SGEN Seattle Genetics Inc /wa Sale 5,825 42.02 244,795
2014-08-24 SGEN Seattle Genetics Inc /wa Sale 3,696 43.55 160,957
2013-08-28 SGEN Seattle Genetics Inc /wa Option Ex 30,366 11.18 339,491
2013-08-27 SGEN Seattle Genetics Inc /wa Sale 37,763 41.45 1,565,200
2013-08-27 SGEN Seattle Genetics Inc /wa Option Ex 37,763 18.36 693,479
2013-08-19 SGEN Seattle Genetics Inc /wa Sale 3,328 40.91 136,148
2013-07-12 SGEN Seattle Genetics Inc /wa Sale 47,527 37.94 1,803,174
2013-07-11 SGEN Seattle Genetics Inc /wa Sale 45,000 36.94 1,662,300
2013-07-12 SGEN Seattle Genetics Inc /wa Option Ex 47,527 13.73 652,545
2013-07-11 SGEN Seattle Genetics Inc /wa Option Ex 45,000 12.08 543,600
2013-03-07 SGEN Seattle Genetics Inc /wa Sale 49,718 30.73 1,527,684
2013-03-07 SGEN Seattle Genetics Inc /wa Option Ex 20,176 11.62 234,546
2012-11-08 SGEN Seattle Genetics Inc /wa Option Ex 72,737 5.42 393,870
2012-09-05 SGEN Seattle Genetics Inc /wa Sale 45,000 27.97 1,258,650
2012-09-06 SGEN Seattle Genetics Inc /wa Option Ex 50,000 12.16 608,000
2012-09-05 SGEN Seattle Genetics Inc /wa Option Ex 45,000 11.62 523,125
2012-09-06 SGEN Seattle Genetics Inc /wa Sale 50,000 28.97 1,448,500
2012-08-24 SGEN Seattle Genetics Inc /wa Option Ex 14,000 10.29 144,060
2012-08-24 SGEN Seattle Genetics Inc /wa Sale 14,000 26.97 377,580
2012-08-27 SGEN Seattle Genetics Inc /wa Option Ex 31,000 10.69 331,390
2012-08-27 SGEN Seattle Genetics Inc /wa Sale 31,000 26.97 836,070
2012-08-16 SGEN Seattle Genetics Inc /wa Option Ex 40,000 10.29 411,599
2012-08-16 SGEN Seattle Genetics Inc /wa Sale 40,000 25.97 1,038,800
2012-06-14 SGEN Seattle Genetics Inc /wa Sale 50,000 24.97 1,248,500
2012-06-14 SGEN Seattle Genetics Inc /wa Option Ex 50,000 5.42 270,750
2012-06-12 SGEN Seattle Genetics Inc /wa Sale 45,000 23.97 1,078,785
2012-06-12 SGEN Seattle Genetics Inc /wa Option Ex 45,000 5.20 234,000
2012-06-08 SGEN Seattle Genetics Inc /wa Option Ex 35,000 5.20 182,000
2012-06-08 SGEN Seattle Genetics Inc /wa Sale 35,000 22.97 803,950
2011-10-07 SGEN Seattle Genetics Inc /wa Sale 24,350 21.97 534,969
2011-10-07 SGEN Seattle Genetics Inc /wa Option Ex 24,350 5.20 126,620
2011-07-18 SGEN Seattle Genetics Inc /wa Option Ex 18,663 4.83 90,048
2011-06-07 SGEN Seattle Genetics Inc /wa Option Ex 10,750 5.20 55,900
2011-06-07 SGEN Seattle Genetics Inc /wa Sale 10,750 19.96 214,570
2011-05-18 SGEN Seattle Genetics Inc /wa Sale 21,250 18.64 396,100
2011-05-18 SGEN Seattle Genetics Inc /wa Option Ex 21,250 4.83 102,531
2011-05-09 SGEN Seattle Genetics Inc /wa Sale 20,000 17.74 354,799
2011-05-09 SGEN Seattle Genetics Inc /wa Option Ex 20,000 4.45 89,000
2011-04-29 SGEN Seattle Genetics Inc /wa Option Ex 15,000 4.45 66,750
2011-04-29 SGEN Seattle Genetics Inc /wa Sale 15,000 16.94 254,100
2007-09-26 SGEN Seattle Genetics Inc /wa Sale 32,250 11.93 384,678
2007-09-26 SGEN Seattle Genetics Inc /wa Option Ex 32,250 5.08 163,668

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Simpson Todd E (Chief Financial Officer of Seattle Genetics Inc /wa at the time of this reporting) see the Securities and Exchange Commission (SEC) website.